ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy-Reference-Cited by-同舟云学术

ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy

Published:2017-09-23 Issue:3 Volume:33 Page:423-426
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Bittar Peter G.¹^ORCID,Nickolich Myles S.²,Onwuemene Oluwatoyosi A.³^ORCID

Affiliation:

1. Duke University School of Medicine; Durham North Carolina

2. Department of Medicine; Duke University Medical Center; Durham North Carolina

3. Division of Hematology, Department of Medicine; Duke University Medical Center; Durham North Carolina

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jca.21590/fullpdf

Reference15 articles.

1. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the seventh special issue;Schwartz;J Clin Apheresis.,2016

2. Gemcitabine-induced thrombotic microangiopathy: a systematic review;Izzedine;Nephrol Dial Transplant.,2006

3. Thrombotic microangiopathy, cancer, and cancer drugs;Izzedine;Am J Kidney Dis.,2015

4. Gemcitabine-associated thrombotic thrombocytopenic purpura;Zupancic;Lancet Oncol.,2007

5. Gemcitabine-induced thrombotic microangiopathy;Richmond;Intern Med J.,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data;British Journal of Haematology;2022-12-07

2. Gemcitabine;Reactions Weekly;2018-09